Navigation Links
Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American Academy of Ophthalmology Meeting
Date:11/19/2013

SEATTLE, Nov. 19, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement (ILR). OMS302 is the company's proprietary Pharmacosurgery® product being developed for all ILR, including cataract surgery and refractive lens exchange.

The analyses were presented by Steve Whitaker, M.D., Omeros' vice president of clinical development and chief medical officer on November 17 at the Annual American Academy of Ophthalmology (AAO) Meeting in New Orleans. The clinical data presented at the AAO meeting and shown below demonstrated that, in these clinical trials in which all patients received standard-of-care preoperative mydriatic topical drops, OMS302 reduced the occurrence of intraoperative pupil constriction. Intraoperative miosis is an important risk factor for surgical complications. As shown in the figure below, pupil constriction of at least 3 millimeters was common in control patients while constriction greater than 1 millimeter was uncommon in OMS302-treated patients.

(Photo: http://photos.prnewswire.com/prnh/20131119/MM19781 )

"We are pleased with the recognition that the recent clinical data for OMS302 received from the ophthalmic community during the AAO annual meetings," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "Ophthalmologists continue to appreciate the potential clinical benefits of OMS302, and we look forward to the drug's expected commercial launch in 2014."

About Omeros' OMS302 Program
OMS302 is Omeros' product being developed for use du
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Research and Markets  has announced the addition ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to inflammation and pain in the human body,s joints such ... causes inflammation of the tissues that surround the joints and ... RA begin slowly, usually just mild pain around the joints ...
(Date:7/28/2014)... 2014  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" ... the development, marketing and distribution of opioid-related immunotherapies, ... materials with the Securities and Exchange Commission in ... to be held on Thursday, September 4, 2014, ... date for determining those shareholders eligible to receive ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, ... Roger Crystal , MD as Vice President of ... Global Business Development Product Acquisition & Licensing team at ... developing business strategy and partnerships in the precision medicine ... partner with biotechnology and pharmaceutical companies across the spectrum ...
Breaking Medicine Technology:Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
... that a new market research report is available ... - Pipeline Assessment and Market Forecasts to 2017 ... Erectile Dysfunction - Pipeline Assessment and Market Forecasts ... healthcare report, "Erectile Dysfunction - Pipeline Assessment and ...
... Reportlinker.com announces that a new market research report ... Epigenetics: Current and future applications that are driving ... Medical Device Company Intelligence ... activities, from its origins to its latest corporate ...
Cached Medicine Technology:Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 2Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 3Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 4Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 5Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 6Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 7Reportlinker Adds Epigenetics: Current and future applications that are driving novel drug discovery 8
(Date:7/28/2014)... City, NY (PRWEB) July 29, 2014 ... Head Nurse at Kings County Hospital Center, as a ... recognized with this prestigious distinction for leadership in community ... in the country, spanning virtually every industry and profession, ... powerfully vibrant networking community with over 600,000 members and ...
(Date:7/28/2014)... Ticket Down is a reputable source ... between Manchester City and Liverpool FC at Yankee Stadium ... countless big events since it opened several years ago. It ... Yankee Stadium, however, it has been a popular destination for ... , The Yankees Stadium is the home of the ...
(Date:7/28/2014)... UHY LLP, a member of the global ... International Business – Issue 29. This bi-annual publication features ... current business challenges and key issues faced by companies ... following topics:, , Key industry sectors ... the next five years? Where are growth opportunities to ...
(Date:7/28/2014)... -- Elementary school students seem to be satisfied with the ... new study of school officials. , , New meal standards ... into effect in the fall of 2012. At the time, ... throw away most of their food. But the new study ... case. , , "The updated meals standards are resulting in ...
(Date:7/28/2014)... York, NY (PRWEB) July 28, 2014 ... the body and it’s considered to be conditionally essential ... stress and is an advanced recovery & Immune System ... all the glutamine your body produces, supplementing with additional ... removal of waste products in the body, digestion and ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 2Health News:Liverpool FC vs. Manchester City Tickets at Yankee Stadium: Ticket Down Reports Huge Demand for Guinness International Champions Cup Tickets in NYC 3Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3
... have uncovered evidence that the abnormal editing of gene messages ... the development of lupus. Scientists hope the finding will lead ... therapy and possibly a new way to treat the disease. ... an enzyme that edits and modifies the messages of genes ...
... At the "World Aquaculture,2008", held on May ... from,the University of Strathclyde, Scotland, United Kingdom, was ... innovative statistical and,epidemiological research methods in sea-lice treatments ... an excellent example of commitment to,the advancement of ...
... money and time spent in intensive care units, researcher ... tubes coated with silver dramatically reduce infections from highly ... breathe through a tube placed through their trachea and ... developing what is called ventilator-associated pneumonia. , "Ventilator-associated pneumonia ...
... Murad, Inc. announced today,the appointment of Fernando Braga, ... for Latin America. In this position, Braga will,develop ... in key,areas, identify prospective partners and create new ... http://www.newscom.com/cgi-bin/prnh/20080519/LAM066 ), "Fernando joins the Murad family ...
... AUSTIN, TexasAging brings a sense of peace and calm, according ... The University of Texas at Austin. Starting at about age ... their younger counterparts. , Catherine Ross and John Mirowsky, professors ... Balance of Emotions in the May 19 issue of Social ...
... Anthem Members in six California, counties - Los Angeles, Alameda, Contra ... of Costs Associated with Medical ... Procedures, ... today the expansion of its industry-leading,transparency initiative into California. Now, approximately 1.8 ...
Cached Medicine News:Health News:Abnormal 'editing' of gene messages may be a cause of lupus 2Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 2Health News:Prof. Dr. George Gettinby Honored With Dieter Lutticken Award 3Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 3Health News:Murad, Inc., Appoints Fernando Braga, Jr. as Director of International Business for Latin America 2Health News:With age comes a sense of peace and calm, population research center study shows 2Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 2Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: